Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04868877
Brief Title: A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

First Submitted : April 9, 2021
First Submitted that Met QC Criteria : April 27, 2021
First Posted : May 3, 2021

Last Update Submitted that Met QC Criteria : May 21, 2021
Last Update Posted : May 24, 2021